Predictive Roles of Urinary Liver Type - Fatty Acid-Binding Protein and N-Acetyl-β-D-Glucosaminidase for Progression of Diabetic Nephropathy in Type 2 Diabetic Patients

Fatty Acid Binding Protein (1 & 2) as Markers of Diabetic Nephropathy in Elderly Patients with Type 2 Diabetes Mellitus

Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease

Circulating Adipocyte Fatty Acid Binding Protein (A-FABP): Predictor of Metabolic Syndrome in Patients with Type 2DM

Prognostic Markers of Severity of Chronic Kidney Disease in Patients with Metabolic Associated Fatty Liver Disease

URINARY LIVER TYPE FATTY ACID BINDING PROTIEN AND PLASMA CYSTATIN C PREDICT ACUTE KIDNEY INJURY OUTCOMES IN CRITICALLY ILL PATIENTS

SERUM LEVELS OF ADIPOCYTE FATTY ACID BINDING PROTEIN 4 AND RETINOL BINDING PROTEIN 4 AS BIOMARKERS FOR EARLY DETECTION OF DIABETIC NEPHROPATHY IN TYPE 2 DIABETES

Relationship Between Serum Adipocyte Fatty Acid Binding Protein and Atherosclerosis in Type 2 Diabetes Patients

Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes

FETUIN A AS AN EARLY MARKER OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS